daughter of Tim McGraw and Faith Hill opened up about her use of Ozempic in a post on Instagram, revealing that she is now using an alternative prescription amid an ongoing health battle with polycystic ovary syndrome (PCOS).
Showing off her figure in a new bikini photo, Gracie cheekily captioned the pic: «It’s a gorgeous day for narcissism!» Then, she hit the comments to respond to one person who called out her use of the controversial Ozempic, which is prescribed to people with diabetes to help control blood sugar and, more recently, has made headlines for its weight loss effect. «I did use Ozempic last year, yes.
I am now on a low dose of Mounjaro for my PCOS as well as working out,» Gracie wrote in the comments. «No need to accuse when I have been open about it.» A post shared by GRACIE MCGRAW (@graciemcgra)Mounjaro is an FDA-approved injectable prescription medication used for the treatment of type 2 diabetes.
It is a brand name version of the drug Tirzepatide and is similar to both Ozempic and Wegovy, which are both brand names for the drug Semaglutide.PCOS is a hormone imbalance that can cause irregular periods, infertility and weight gain, among other symptoms, according to Johns Hopkins Medicine.Last March, Gracie revealed that she had been diagnosed with PCOS.
Read more on etonline.com
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.